#Biostar_Pharma

Biostar Pharma's UTD1 Begins Pivotal Trial for Treating Brain Metastases from Breast Cancer Biostar Pharma's UTD1 has officially begun patient dosing in the U.S., marking a significant step in treating brain metastases in breast cancer.

Biostar Pharma's UTD1 Begins Pivotal Trial for Treating Brain Metastases from Breast Cancer #United_States #San_Francisco #Breast_Cancer #Biostar_Pharma #UTD1

FDA Grants Third Orphan Drug Designation to Biostar Pharma's Utidelone for Pancreatic Cancer Treatment Biostar Pharma's Utidelone receives Orphan Drug Designation from the FDA to treat pancreatic cancer, highlighting its potential benefits against this difficult disease.

FDA Grants Third Orphan Drug Designation to Biostar Pharma's Utidelone for Pancreatic Cancer Treatment #United_States #San_Francisco #pancreatic_cancer #Utidelone #Biostar_Pharma